Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 May;16(5):338-350.
doi: 10.1038/nrd.2016.232. Epub 2016 Dec 23.

Advances in islet encapsulation technologies

Tejal Desai  1 , Lonnie D Shea  2
Affiliations
Review

Advances in islet encapsulation technologies

Tejal Desai et al. Nat Rev Drug Discov. 2017 May.

Erratum in

Abstract

Type 1 diabetes is an autoimmune disorder in which the immune system attacks and destroys insulin-producing islet cells of the pancreas. Although islet transplantation has proved to be successful for some patients with type 1 diabetes, its widespread use is limited by islet donor shortage and the requirement for lifelong immunosuppression. An encapsulation strategy that can prevent the rejection of xenogeneic islets or of stem cell-derived allogeneic islets can potentially eliminate both of these barriers. Although encapsulation technology has met several challenges, the convergence of expertise in materials, nanotechnology, stem cell biology and immunology is allowing us to get closer to the goal of encapsulated islet cell therapy for humans.

PubMed Disclaimer

Figures

Figure 1 ∣
Figure 1 ∣. Islet and β-cell transplantation systems.
a ∣ Schematic of the ViaCyte device, which is a rechargeable encapsulating system about half the size of a business card in which the membrane functions to contain the cells and to limit the access of immune cells, but allows the transport of nutrients from the exterior of the device and hormones from the encapsulated cells. Patients would be implanted with 4–6 units. b ∣ Image and schematic of the Beta-O2 device demonstrating the ports for recharging oxygen and the encapsulation device. The schematic illustrates the central module that can be charged with oxygen to diffuse outwards to the islets contained within a membrane. The device is approximately 2.5 inches in diameter. The membrane allows for nutrient and hormone transport but is impregnated with alginate to restrict cell infiltration. c ∣ Islet microencapsulation with alginate hydrogels. This image shows genetically engineered pig islets entrapped within alginate hydrogels. d ∣ Host response to the transplantation of encapsulated islets. Transplantation of the capsules leads to a host response that will depend on multiple factors (for example, cells, materials, transplant site and so on). Shortly after transplantation into tissues (left-hand side), the host response to transplantation and the material can consist of an inflammatory response (pink region) with nearby blood vessels. Over time, the inflammatory response would ideally resolve without fibrosis and would allow for vascular growth adjacent to the capsule for nutrient and hormone exchange. However, shed antigens released from the islet may contribute to immune cell recruitment and activation. PTFE, polytetrafluoroethylene.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Centers for Disease Control and Prevention. Diabetes report card 2014. CDC; http://www.cdc.gov/diabetes/pdfs/library/diabetesreportcard2014.pdf (2015).
    1. National Center for Chronic Disease Prevention and Health Promotion. National diabetes statistics report, 2014: estimates of diabetes and its burden in the United States. CDC; http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-... (2014).
    1. Ryan EA et al. Five-year follow-up after clinical islet transplantation. Diabetes 54, 2060–2069 (2005). - PubMed
    1. Barton FB et al. Improvement in outcomes of clinical islet transplantation: 1999–2010. Diabetes Care 35, 1436–1445 (2012). - PMC - PubMed
    1. Shapiro AM et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med 343, 230–238 (2000). - PubMed

MeSH terms